期刊
FUTURE MICROBIOLOGY
卷 2, 期 6, 页码 583-590出版社
FUTURE MEDICINE LTD
DOI: 10.2217/17460913.2.6.583
关键词
clinical trials; Cryptosporidium; Giardia; nitazoxanide
类别
Nitazoxanide is a new compound with broad-spectrum activity against numerous intestinal protozoa, helminths and anaerobic bacteria. It is approved for the treatment of diseases caused by Giardia intestinalis and Cryptosporidium species. The drug is well tolerated, with few side effects and requires a short course of treatment. Further investigations regarding its use in patients with AIDS is needed. Nitazoxanide represents a significant advance in the treatment of intestinal parasitic infections worldwide.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据